论文部分内容阅读
Objective:To evaluate the clinical value of trastuzumab and chemotherapy in patients with Her2-positive locally advanced breast cancer.Methods:Fifty patients with Her2-positive locally advanced breast cancer admitted to our hospital from March 2017 to Mar